LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10700 | 10401 | 1.0288 | 1.0303 |
MCF 10A | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10414 | 10401 | 1.0012 | 1.0013 |
MCF 10A | KIN001-043 | 0.37 | uM | LJP6 | 72 | hr | 513 | 10145 | 10401 | 0.9754 | 0.9741 |
MCF 10A | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 513 | 7173 | 10401 | 0.6897 | 0.6736 |
MCF 10A | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 513 | 476 | 10401 | 0.0458 | -0.0038 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 513 | 692 | 10401 | 0.0666 | 0.0181 |
MCF 10A | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 513 | 2270 | 10401 | 0.2183 | 0.1777 |
MCF 10A | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 513 | 9649 | 10401 | 0.9277 | 0.9239 |
MCF 10A | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 513 | 9226 | 10401 | 0.8871 | 0.8812 |
MCF 10A | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 513 | 5345 | 10401 | 0.5140 | 0.4887 |
MCF 10A | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8239 | 10401 | 0.7921 | 0.7813 |
MCF 10A | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 513 | 1414 | 10401 | 0.1360 | 0.0911 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9301 | 10401 | 0.8943 | 0.8888 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 513 | 5559 | 10401 | 0.5345 | 0.5104 |
MCF 10A | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 513 | 6485 | 10401 | 0.6236 | 0.6040 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 737 | 10401 | 0.0709 | 0.0226 |
MCF 10A | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 513 | 6411 | 10401 | 0.6164 | 0.5965 |
MCF 10A | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 513 | 685 | 10401 | 0.0659 | 0.0174 |
MCF 10A | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 513 | 572 | 10401 | 0.0550 | 0.0059 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8716 | 10401 | 0.8380 | 0.8296 |
MCF 10A | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10181 | 10401 | 0.9788 | 0.9777 |
MCF 10A | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10725 | 10401 | 1.0312 | 1.0328 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 8666 | 10401 | 0.8332 | 0.8245 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 6977 | 10401 | 0.6708 | 0.6537 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 792 | 10401 | 0.0761 | 0.0282 |